Bifido's reported results run from a 2024 operating loss as the trough, through a return to operating profit in 2025, to quarter-to-quarter swings in 2026.
Annual sales were KRW 14.6 billion in 2022, KRW 18.6 billion in 2023 (up 27.8% year on year), KRW 12.4 billion in 2024 (down 33.7%), and KRW 19.7 billion in 2025 (up 59.3%). Of the 2022 to 2025 period, 2025 was the largest year and 2024 the smallest.
Operating profit fell from KRW 1.26 billion in 2022 to an operating loss of KRW 344 million in 2023, and the loss widened to KRW 4.49 billion in 2024. Operating profit of KRW 1.4 billion in 2025 marked a return to profit. The operating margin moved from 8.7% in 2022 to -1.8% in 2023, -36.4% in 2024 and 7.1% in 2025.
Net income attributable to controlling shareholders was KRW 1.55 billion in 2022 and KRW 1.08 billion in 2023 (down 30.0%), then turned to a net loss of KRW 5.4 billion in 2024. The 2025 net loss narrowed to KRW 193 million, and the company has posted losses for two consecutive years, 2024 and 2025.
Net income including non-controlling interests followed the same direction, at a net loss of KRW 5.4 billion in 2024 and KRW 193 million in 2025. Operating cash flow went from negative KRW 716 million in 2024 to KRW 3.95 billion in 2025.
The debt ratio moved from 4.7% in 2022 to 38.7% in 2023, 31.1% in 2024 and 33.5% in 2025. At the end of 2025, total equity was KRW 45.9 billion and total liabilities were KRW 15.4 billion. On a quarterly basis, the third quarter of 2025 showed sales of KRW 3.71 billion and an operating loss of KRW 375 million.
The fourth quarter brought sales of KRW 4.83 billion (up 30.3% quarter on quarter) and operating profit of KRW 360 million, a return to profit, while the net loss attributable to controlling shareholders widened to KRW 914 million.
First-quarter 2026 sales fell to KRW 2.5 billion (down 48.3% quarter on quarter) with an operating loss of KRW 597 million.
Net income attributable to controlling shareholders nonetheless turned positive at KRW 2.67 billion, and the gap between the operating loss and this net income can be traced to non-operating items.
Second-quarter 2026 sales rose to KRW 3.6 billion (up 44.3%), with an operating loss of KRW 410 million and net income attributable to controlling shareholders of KRW 318 million.
Third-quarter 2026 sales reached KRW 4.27 billion (up 18.6% quarter on quarter and 15.3% year on year), with an operating loss of KRW 68.78 million and a net loss attributable to controlling shareholders of KRW 33.78 million.
Sales rose for two consecutive quarters, and the operating loss narrowed in both the second and third quarters. The sum of net income attributable to controlling shareholders over the last four quarters, from the fourth quarter of 2025 to the third quarter of 2026, was KRW 2.04 billion.